BioZorb – A New Implantable Device Delimiting Surgical Site After Breast Cancer Lumpectomy

BioZorb – A New Implantable Device Delimiting Surgical Site After Breast Cancer Lumpectomy
biozorb_purpleDuring the 32nd Annual Miami Breast Cancer Conference in Miami Beach, Florida, held between Feb. 26 to March 1, new innovative and challenging surgical, medical and radiation approaches were presented that promote the understanding of state-of-the-art treatments within each therapeutic area and collaborative work in the clinic. During the conference Dr. Steven Schonholz from the Noble Hospital, Massachusetts, presented a scientific poster with the BioZorb tissue marker a new implantable device that specifically delimits the surgical site of tissue removal (lumpectomy) in three dimensions in patients with breast cancer. Dr. Schonholz is the Director of the Center for Comprehensive Breast Health at Noble Hospital and was the first physician in Massachusetts to use BioZorb during his clinical practice. The BioZorb tissue marker was developed by Focal Therapeutics. It has 6 titanium marker clips distributed in a 3D pattern inside a bio-absorbable coil that enables the delivery of a more focused radiation therapy with lower amount of radiation reaching the healthy tissues. By delimiting the surgical site, this device improves visual confirmation for therapy planning, patient positioning and follow-up. BioZorb is compatible with virtually all forms of radiation therapy and is frequently used in the breast. The coil can be reabsorbed by the body w
Subscribe or to access all post and page content.